Bahadorizadeh Leyla, Emamikhah Maziar, Pour Mohammad Arash, Gholizadeh Mesgarha Milad
Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Department of Neurology, Rasool-E Akram Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Neurol Ther. 2022 Mar;11(1):491-497. doi: 10.1007/s40120-021-00294-9. Epub 2021 Oct 29.
Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic, multiple but rare complications of this infection have been described, comprising cerebral venous sinus thrombosis (CVST) and immune thrombocytopenic purpura (ITP). Although these two complications have been reported as separate entities, to the best of our knowledge, their concurrent presentation has not been reported. In this case report, we present a middle-aged man with a history of COVID-19 infection who developed a sudden-onset severe occipital headache followed by right-sided blindness (right homonymous hemianopia). Upon his diagnostic workup, brain computed tomography scan with and without contrast was indicative of thrombosis of the left transverse venous sinus and hemorrhagic venous infarction. In addition, laboratory data revealed thrombocytopenia, which upon investigation confirmed a diagnosis of ITP. We postulate three pathophysiological mechanisms for this circumstance: either COVID-19 infection caused ITP and then ITP gave rise to CVST, or COVID-19 complications themselves resulted in ITP and CVST independently and simultaneously, or another plausible mechanism is immune-mediated thrombocytopenia caused by the anti-platelet 4-factor antibody, which is the proposed mechanism for CVST after the COVID-19 vaccine.
自2019冠状病毒病(COVID-19)大流行出现以来,已描述了这种感染的多种但罕见的并发症,包括脑静脉窦血栓形成(CVST)和免疫性血小板减少性紫癜(ITP)。尽管这两种并发症已被分别报道,但据我们所知,它们同时出现的情况尚未见报道。在本病例报告中,我们介绍了一名有COVID-19感染病史的中年男性,他突然出现严重的枕部头痛,随后出现右侧失明(右侧同向性偏盲)。在其诊断检查中,增强和未增强的脑部计算机断层扫描显示左侧横窦血栓形成和出血性静脉梗死。此外,实验室数据显示血小板减少,经检查确诊为ITP。我们推测这种情况有三种病理生理机制:要么是COVID-19感染导致ITP,然后ITP引发CVST;要么是COVID-19并发症本身独立且同时导致ITP和CVST;或者另一种合理的机制是抗血小板4因子抗体引起的免疫介导性血小板减少,这是COVID-19疫苗接种后CVST的推测机制。